Latest ARCT reports update at 2024-03-14: 2023 ∙ 2022 ∙ 2021

Arcturus Therapeutics Holdings ARCT

$ 27.27 2.83%

Arcturus Therapeutics Holdings Financial Statements 2011-2024 | ARCT

Annual Financial Statements Arcturus Therapeutics Holdings

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	968 M	962 M	688 M	1.47 B	125 M	50.3 M	24.7 M	28.7 M	111 M	84.4 M	223 M	20.7 M	-
Shares	26.6 M	26.4 M	26.3 M	20.3 M	12.1 M	10.1 M	3.09 M	3.94 M	3.09 M	1.95 M	1.45 M	1.59 M	-
Historical Prices	36.4	36.4	26.1	72.5	10.3	5	7.76	7.35	35.8	43.2	153	-	-
Net Income	-29.7 M	9.35 M	-204 M	-72.1 M	-26 M	-21.8 M	-10.9 M	-24.6 M	-19.4 M	-32.8 M	-10.5 M	-1.58 M	-3.93 M
Revenue	167 M	206 M	12.4 M	9.54 M	20.8 M	15.8 M	13 M	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	9.54 M	-	-	-	-	-	-	-	-	-
Operating Income	-78.2 M	12.2 M	-203 M	-71.5 M	-25.5 M	-21.8 M	-	-	-	-	-	-	-
Interest Expense	16.6 M	-420 K	-1.92 M	-361 K	-446 K	328 K	-	-	-	-	-	-	-
EBITDA	-75.2 M	13.7 M	-202 M	-70.6 M	-24.8 M	-21.2 M	-10.1 M	-25.1 M	-19.6 M	-33 M	-10.3 M	-1.49 M	-3.88 M
Operating Expenses	245 M	194 M	215 M	81.1 M	46.3 M	37.6 M	23.5 M	25.2 M	19.7 M	33.1 M	-	-	-
General and Administrative Expenses	52.9 M	46.1 M	41.5 M	23.2 M	12.7 M	20.6 M	7.57 M	5.36 M	4.99 M	5.84 M	3.22 M	683 K	2.08 M

All numbers in USD currency

Quarterly Income Statement Arcturus Therapeutics Holdings

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	26.6 K	26.6 K	26.6 K	26.6 M	26.5 K	26.4 K	26.4 K	26.4 M	26.3 M	26.3 M	26.2 M	24.9 M	22.9 M	18.8 M	14.5 M	14.5 M	13.2 M	10.4 M	10.1 M	10.7 M	10.1 M	10.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-16.2 M	-52.6 M	50.8 M	-	-35.3 M	-21.6 M	-51.2 M	-38.7 M	-54.1 M	-54.6 M	-56.3 M	-31.1 M	-21 M	-10.3 M	-9.78 M	-11 M	-7.43 M	-685 K	-6.88 M	-	-4.25 M	-9.95 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	45.1 M	10.5 M	80.3 M	-	13.4 M	27.1 M	5.24 M	5.79 M	2.44 M	2 M	2.13 M	2.24 M	2.33 M	2.32 M	2.65 M	2.97 M	3.32 M	10.2 M	4.35 M	-	3.42 M	2.39 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-19.3 M	-55.4 M	14.8 M	-	-36.8 M	-22.1 M	-50.4 M	-37.6 M	-53.8 M	-53.7 M	-57.7 M	-31.1 M	-20.9 M	-10 M	-9.46 M	-10.8 M	-7.62 M	-572 K	-6.51 M	-	-4.36 M	-10.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	3.98 M	3.25 M	2.48 M	-	-321 K	-560 K	-564 K	-	-519 K	-520 K	-358 K	-	-66 K	-121 K	-152 K	-	-120 K	-113 K	-88 K	-	150 K	169 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-18.5 M	-54.7 M	15.3 M	-	-36.4 M	-21.7 M	-50.2 M	-37.6 M	-53.5 M	-53.4 M	-57.4 M	-31.1 M	-20.7 M	-9.84 M	-9.28 M	-10.8 M	-7.42 M	-372 K	-6.34 M	-	-4.16 M	-9.97 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	64.5 M	65.9 M	65.5 M	-	50.2 M	49.2 M	55.6 M	-	56.3 M	55.7 M	59.8 M	-	23.3 M	12.4 M	12.1 M	-	10.9 M	10.7 M	10.9 M	-	7.78 M	12.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	13.4 M	13.2 M	13.8 M	-	12.5 M	11 M	10.7 M	10.8 M	10.9 M	10 M	9.74 M	9.03 M	5.57 M	4.42 M	4.19 M	1.79 M	3.88 M	3.46 M	3.53 M	-	3.81 M	8.23 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency